CDFI引导下经皮微波热凝固联合血管介入法治疗肝癌的综合应用  

Clinical application of combination therapy with blood vessel intervention and percutaneous microwave coagulation therapy for liver cancer

作　　者：徐延峰[1] 丁兆军[2] 胡冰[1] 刘蕾[1] 接连利[1] 吴乃森[1] 

机构地区：[1]日照市人民医院超声科,山东日照276826 [2]日照市人民医院肿瘤科,山东日照276826

出　　处：《中华肿瘤防治杂志》2006年第21期1655-1657,共3页Chinese Journal of Cancer Prevention and Treatment

摘　　要：目的:探讨应用彩色多普勒超声显像(CDFI)引导经皮微波热凝固(PMCT)联合血管介入法治疗肝癌的可行性与治疗效果。方法:56例肝癌患者,应用PMCT治疗26例,30个结节;PMCT联合TACE30例,42个结节,先行肝动脉化疗栓塞(TACE),3d后行PMCT治疗,其中8例合并门静脉癌栓的病例,在TACE治疗2周后行经皮门静脉化疗(PVC)。结果:肿瘤<5cm的肝癌结节53个,PMCT与联合治疗组均获较好疗效。肿瘤≥5.0cm的19个结节中,联合治疗组在肿瘤缩小、血流信号消失、生存期方面均优于PMCT组。结论:PMCT联合TACE治疗肝癌具有协同作用,是中晚期肝癌有效的综合治疗方法。OBJECTIVE：To investigate the effects of combination transcatheter arterial （TACE） chemoembolization and percutaneous microwavecoagulation therapy（PMCT） in the treatment of liver cancer. METHODS： Fifty-six patients with liver cancer were divided into two groups. Twenty-six patients with 30 tumors were treated by PMCT. Thirty patients with 32 tumors were treated by TACE followed by PMCT 3 days later. Of them, eight patients with portal vein cancerous embolism were followed by percutaneous portal vein chemotherapy（PVC） two weeks after TACE. RESULTS： Fifty-three tumors measuring 〈5 cm in greatest dimension showed very good response by PMCT or by the combination therapy. There were better duction in the reduction rate of tumor size, disappearance of blood flow in tumor and patient survival time in combination therapy group than those in PMCT group. CONCLUSION： Combination therapy with TACE and PMCT was effective in treating liver cancer.

关 键 词：肝肿瘤/治疗 微波/治疗应用 化学栓塞 治疗性 

分 类 号：R735.7[医药卫生—肿瘤]